| Literature DB >> 31737622 |
Kai Wang1,2, Qing-Wei Zhao1,3, Yi-Fan Liu1,2, Chen-Fan Sun1,2, Xin-Ai Chen1,2, Richard Burchmore4, Karl Burgess5, Yong-Quan Li1,2, Xu-Ming Mao1,2.
Abstract
Efficient genome editing is a prerequisite of genetic engineering in synthetic biology, which has been recently achieved by the powerful CRISPR/Cas9 system. However, the toxicity of Cas9, due to its abundant intracellular expression, has impeded its extensive applications. Here we constructed a genetic cassette with triple controls of Cas9 activities at transcriptional, translational and protein levels, together with over-expression of the ATP synthase β-subunit AtpD, for the efficient genome editing in Streptomyces. By deletion of actII-ORF4 in Streptomyces coelicolor as a model, we found that constitutive expression of cas9 had about 90% editing efficiency but dramatically reduced transformation efficiency by 900-fold. However, triple controls of Cas9 under non-induction conditions to reduce its activity increased transformation efficiency over 250-fold, and had about 10% editing efficiency if combined with atpD overexpression. Overall, our strategy accounts for about 30-fold increased possibility for successful genome editing under the non-induction condition. In addition, about 80% editing efficiency was observed at the actII-ORF4 locus after simultaneous induction with thiostrepton, theophylline and blue light for Cas9 activity reconstitution. This improved straightforward efficient genome editing was also confirmed in another locus redD. Thus, we developed a new strategy for efficient genome editing, and it could be readily and widely adaptable to other Streptomyces species to improve genetic manipulation for rapid strain engineering in Streptomyces synthetic biology, due to the highly conserved genetic cassettes in this genus.Entities:
Keywords: Streptomyces; genome editing; homologous recombination; inducible Cas9 activity; pleiotropic controls
Year: 2019 PMID: 31737622 PMCID: PMC6839703 DOI: 10.3389/fbioe.2019.00304
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Figure 1Engineered controls of Cas9 activities and ATP supply for genome editing. (A) Strategy for the stepwise controls of Cas9 under the expression of tipAp, riboswitch and blue light for the pleiotropic controls at transcriptional (I), translational (II), and protein (III) levels. The ATP synthase gene atpD from S. coelicolor was additionally overexpressed under ermEp* (IV). (B,C) Two vectors containing genetic cassettes based on pIJ101 ori (from pWHU2653) and pSG5 ori (pKC1139) were shown as pWHU2653-TRMA (B) and pKC1139-TRMA (C), respectively. All the genetic cassettes were labeled as in (A) and multiple-cloning sites are shown in bold.
Figure 2actII-ORF4 editing in S. coelicolor with fine-tuned controls of Cas9 and overexpression of atpD on the pIJ101 ori plasmid under non-induction conditions. (A) Diagram of actII-ORF4 deletion in S. coelicolor based on engineered controls of Cas9. The primers for diagnostic PCR were shown as arrows, and the predicted sizes of PCR fragments in wild type (M145) and the ΔactII-ORF4 mutant were also shown. The two 2.1 kb fragments are the predicted upstream and downstream PCR products at actII-ORF4 locus of wild type, while the two 1.35 kb fragments are the corresponding PCR products after actII-ORF4 is deleted in the mutant. Desired genome editing is verified by simultaneous genotype investigation of the upstream and downstream regions by PCR. (B) Transformation efficiency during actII-ORF4 deletion in S. coelicolor with various combinatory controls of Cas9 activities based on the pIJ101 ori plasmid. The estimated transformants were shown as mean ± SD (standard deviation) from three independent transformations, and the average transformant numbers were shown on the corresponding columns. ribo, theophylline-inducible riboswitch; TM, both Cas9 N713-pMag and nMagHigh1-Cas9 C714 split fusions expressed under tipAp; TRM, both Cas9 N713-pMag and nMagHigh1-Cas9 C714 splits expressed under tipAp and riboswitch; TRMA, overexpressed atpD along with TRM. Statistical significance (P < 0.001 or P < 0.05) was determined by two-tailed unpaired Student's test. (C,D) Diagnostic PCR for CRISPR/Cas9-based actII-ORF4 deletion with Cas9 expressed from tipAp (C) or with engineered control of Cas9 (D) as shown in Figure 1A. The successfully edited mutants were indicated with asterisks.
Figure 3actII-ORF4 deletion in S. coelicolor with engineered Cas9 and atpD overexpression from the pSG5 ori plasmid under non-induction conditions. (A) Transformation efficiency for actII-ORF4 deletion in S. coelicolor with engineered controls of Cas9 activities as in Figure 2B, but based on the pSG5 ori plasmid. The estimated transformants were shown as mean ± SD (standard deviation) from three independent transformations, and the average transformant numbers were shown on the corresponding columns. Statistical significance (P < 0.001) was determined by two-tailed unpaired Student's test. (B) Diagnostic PCR for actII-ORF4 deletion based on the same strategy as Figure 2D, but with pSG5 ori on the pKC1139 plasmid. The successfully deleted strains were indicated with asterisks.
Figure 4actII-ORF4 deletion in S. coelicolor with engineered Cas9 and atpD overexpression from the pSG5 ori plasmid under induction conditions. The unedited transformants containing pKC1139-TRMA-cas9 in the single cross-over (A) or replicative form (B) from Figure 3B were simultaneously induced with thiostrepton, theophylline and blue light, and the genotype of twenty single colonies was investigated with diagnostic PCR as in Figure 2A. The successfully deleted strains were indicated with asterisks.